Mrignayani Kotecha
Overview
Explore the profile of Mrignayani Kotecha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
373
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Canavesi I, Viswakarma N, Khurana R, Epel B, Kuppusamy P, Pagel M, et al.
Magn Reson Med
. 2025 Jan;
93(5):2239-2249.
PMID: 39831522
Purpose: Solid crystalline spin probes, such as lithium phthalocyanine (LiPc) and lithium octa-n-butoxynaphthalocyanine (LiNc-BuO), allow repeated oxygen measurement using electron paramagnetic resonance (EPR). Due to their short relaxation times, their...
2.
Canavesi I, Viswakarma N, Epel B, Kotecha M
Mol Imaging Biol
. 2024 Dec;
27(1):64-77.
PMID: 39633071
Purpose: Type 1 diabetes (T1D) is an autoimmune disease that leads to the loss of insulin-producing pancreatic beta cells. Beta cell replacement devices or bioartificial pancreas (BAP) have shown promise...
3.
Kotecha M, Pagel M
Mol Imaging Biol
. 2024 Jan;
26(3):371-372.
PMID: 38243146
No abstract available.
4.
Epel B, Viswakarma N, Hameed S, Freidin M, Abrams C, Kotecha M
Magn Reson Med
. 2024 Jan;
91(6):2519-2531.
PMID: 38193348
Purpose: The determination of blood-brain barrier (BBB) integrity and partial pressure of oxygen (pO) in the brain is of substantial interest in several neurological applications. This study aimed to assess...
5.
Gertsenshteyn I, Epel B, Giurcanu M, Barth E, Lukens J, Hall K, et al.
Front Med (Lausanne)
. 2023 Dec;
10:1339872.
PMID: 38116039
[This corrects the article DOI: 10.3389/fmed.2023.1269689.].
6.
Wang L, Marfil-Garza B, Ernst A, Pawlick R, Pepper A, Okada K, et al.
Nat Biomed Eng
. 2023 Dec;
8(10):1266-1284.
PMID: 38052996
Cellular therapies for type-1 diabetes can leverage cell encapsulation to dispense with immunosuppression. However, encapsulated islet cells do not survive long, particularly when implanted in poorly vascularized subcutaneous sites. Here...
7.
Colombani T, Bhatt K, Epel B, Kotecha M, Bencherif S
Mater Adv
. 2023 Nov;
4(15):3084-3090.
PMID: 38013688
Recent advances in our understanding of hypoxia and hypoxia-mediated mechanisms shed light on the critical implications of the hypoxic stress on cellular behavior. However, tools emulating hypoxic conditions (, low...
8.
Shaw M, Poncelet M, Viswakarma N, Vallerini G, Hameed S, Gluth T, et al.
Mol Imaging Biol
. 2023 Nov;
26(3):542-552.
PMID: 37945971
Purpose: This study aimed to develop a biocompatible oximetric electron paramagnetic resonance (EPR) spin probe with reduced self-relaxation, and sensitivity to oxygen for a higher signal-to-noise ratio and longer relaxation...
9.
Gertsenshteyn I, Epel B, Giurcanu M, Barth E, Lukens J, Hall K, et al.
Front Med (Lausanne)
. 2023 Oct;
10:1269689.
PMID: 37904839
Background: Clinical attempts to find benefit from specifically targeting and boosting resistant hypoxic tumor subvolumes have been promising but inconclusive. While a first preclinical murine tumor type showed significant improved...
10.
Martin R, Diaz S, Poncelet M, Driesschaert B, Barth E, Kotecha M, et al.
Mol Imaging Biol
. 2023 Oct;
26(3):525-541.
PMID: 37870648
Purpose: Progress toward developing a novel radiocontrast agent for determining pO in tumors in a clinical setting is described. The imaging agent is designed for use with electron paramagnetic resonance...